Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance

SELLAS Life Sciences Group Inc. Common StockTrade
Vipshop Holdings Ltd - ADRTrade

Price performance (Past 24H)

Key statistics

SELLAS Life Sciences Group Inc. Common Stock vs Vipshop Holdings Ltd - ADR — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B), while Vipshop Holdings Ltd - ADR trades at $12.71 (market cap $6.07B). The key difference: Vipshop Holdings Ltd - ADR is far larger — about 2.7× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Vipshop Holdings Ltd - ADR pays a 4.86% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.

SLSVIPS
Market Cap
$2.28B$6.07B
Volume
3,128,9603,134,219
Sector
HealthConsumer Cyclical
52-Week High
$15.46$20.29
52-Week Low
$1.39$12.09
Enterprise Value
$2.15B$2.90B
Typical Hold Time
—49 Days
Dividend Yield
—4.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Vipshop Holdings Ltd - ADR

Vipshop (VIPS) trades at $12.72, down 0.24% on the day, with a bullish overall technical signal. The stock appears undervalued with a P/E of 4.12 and P/S of 0.41, supported by strong profitability metrics including a 9.82% net income margin and 24.44% ROE. Recent Q2 2026 earnings missed expectations, with revenue of $105.92 billion in 2025 showing a slight decline, but net income remains robust at $7.24 billion. Analyst consensus is bullish with a $16.17 price target.

The outlook for VIPS is mixed; attractive valuation and strong cash flow generation offer upside potential, but recent earnings misses and a challenging consumer environment pose near-term risks. Investor sentiment is cautiously optimistic, with 53.57% of analysts rating it a buy, though growth stagnation remains a key concern.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SLS

No sentiment data available yet.

VIPS
0% Buy100% Sell
Avg holding period · 49 Days

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →

About Vipshop Holdings Ltd - ADR

Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.

Read more on VIPS →